You are using an outdated browser. Please upgrade your browser to improve your experience.

empagliflozin

Ligand Summary
Ligand Structure
Rendered image for the query structure
Description
Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion.
Synonyms & Links
Guide to Pharmacology: 4754
DrugCentral: 4830
LyCHI:  QKPY8TZ7VLHD


Target Activities